Wauters J - Search Results

1

The Eagle-like effect of echinocandins: what's in a name?

Vanstraelen K, Lagrou K, Maertens J, Wauters J, Willems L, Spriet I. Vanstraelen K, et al. Among authors: wauters j. Expert Rev Anti Infect Ther. 2013 Nov;11(11):1179-91. doi: 10.1586/14787210.2013.841543. Epub 2013 Oct 18. Expert Rev Anti Infect Ther. 2013. PMID: 24134556 Review.

2

Pharmacokinetics of voriconazole during continuous venovenous hemofiltration.

Spriet I, Wauters J, Willems L. Spriet I, et al. Among authors: wauters j. Ther Drug Monit. 2011 Jun;33(3):372; author reply 372. doi: 10.1097/FTD.0b013e31821f38bf. Ther Drug Monit. 2011. PMID: 21566509 No abstract available.

3

Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study.

Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, Lagrou K, Wilmer A, Jorens P, Hermans G. Wauters J, et al. Intensive Care Med. 2012 Nov;38(11):1761-8. doi: 10.1007/s00134-012-2673-2. Epub 2012 Aug 16. Intensive Care Med. 2012. PMID: 22895826 Free PMC article.

4

Invasive pulmonary aspergillosis in the ICU: reply to Wichmann et al.

Wauters J, Lagrou K, Wilmer A, Jorens P, Hermans G. Wauters J, et al. Intensive Care Med. 2013 Apr;39(4):791. doi: 10.1007/s00134-012-2810-y. Epub 2013 Jan 22. Intensive Care Med. 2013. PMID: 23338572 Free article. No abstract available.

5

The influence of continuous venovenous renal replacement therapy on the plasma disappearance rate of indocyanine green.

Ameloot K, Meersseman P, Wilmer A, Hermans G, Gerits A, Spriet I, Wauters J. Ameloot K, et al. Among authors: wauters j. Intensive Care Med. 2013 Dec;39(12):2231-2. doi: 10.1007/s00134-013-3101-y. Epub 2013 Oct 8. Intensive Care Med. 2013. PMID: 24100945 No abstract available.

6

Pharmacokinetic changes after placement of a transjugular intrahepatic portosystemic shunt.

De Winter S, Verelst S, Wauters J, Van der Linden L, Verslype C, Willems L, Spriet I. De Winter S, et al. Among authors: wauters j. Eur J Clin Pharmacol. 2014 Mar;70(3):377-8. doi: 10.1007/s00228-013-1629-y. Epub 2013 Dec 19. Eur J Clin Pharmacol. 2014. PMID: 24352633 No abstract available.

7

Coxsackievirus A16 encephalitis during obinutuzumab therapy, Belgium, 2013.

Eyckmans T, Wollants E, Janssens A, Schoemans H, Lagrou K, Wauters J, Maertens J. Eyckmans T, et al. Among authors: wauters j. Emerg Infect Dis. 2014 May;20(5):913-5. doi: 10.3201/eid2005.131766. Emerg Infect Dis. 2014. PMID: 24751368 Free PMC article. No abstract available.

8

Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis.

Vanstraelen K, Wauters J, De Loor H, Vercammen I, Annaert P, Lagrou K, Spriet I. Vanstraelen K, et al. Among authors: wauters j. J Pharm Sci. 2014 Aug;103(8):2565-70. doi: 10.1002/jps.24064. Epub 2014 Jun 24. J Pharm Sci. 2014. PMID: 24961809

9

Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.

Vanstraelen K, Wauters J, Vercammen I, de Loor H, Maertens J, Lagrou K, Annaert P, Spriet I. Vanstraelen K, et al. Among authors: wauters j. Antimicrob Agents Chemother. 2014 Nov;58(11):6782-9. doi: 10.1128/AAC.03641-14. Epub 2014 Sep 2. Antimicrob Agents Chemother. 2014. PMID: 25182655 Free PMC article.

10

Factors impacting unbound vancomycin concentrations in different patient populations.

Oyaert M, Spriet I, Allegaert K, Smits A, Vanstraelen K, Peersman N, Wauters J, Verhaegen J, Vermeersch P, Pauwels S. Oyaert M, et al. Among authors: wauters j. Antimicrob Agents Chemother. 2015 Nov;59(11):7073-9. doi: 10.1128/AAC.01185-15. Epub 2015 Sep 8. Antimicrob Agents Chemother. 2015. PMID: 26349820 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page